Valion Bio (VBIO) Other Operating Expenses (2021 - 2025)

Valion Bio has reported Other Operating Expenses for 5 years, with the latest figure at -$117000.0 in Q3 2025.

• On a quarterly basis, Other Operating Expenses changed N/A year-over-year to -$117000.0 in Q3 2025; TTM through Sep 2025 was $729000.0, a 11.42% decrease from a year earlier, with the FY2024 full-year figure at $1.2 million, down 28.28% from the prior year.
• Other Operating Expenses was -$117000.0 for Q3 2025 at Valion Bio, down from $426000.0 in the prior quarter.
• The five-year high for Other Operating Expenses was $497000.0 in Q2 2022, with the low at -$117000.0 in Q3 2025.
• Average Other Operating Expenses over 5 years is $300500.0, with a median of $325000.0 recorded in 2021.
• The sharpest annual moves came in 2022 and 2024: Other Operating Expenses jumped 158.85% in 2022, then sank 54.2% in 2024.
• Over 5 years, Other Operating Expenses stood at $313000.0 in 2021, then soared by 38.98% to $435000.0 in 2022, then slipped by 17.24% to $360000.0 in 2023, then plunged by 33.06% to $241000.0 in 2024, then tumbled by 148.55% to -$117000.0 in 2025.
• The last three Other Operating Expenses figures came in at -$117000.0 (Q3 2025), $426000.0 (Q2 2025), and $179000.0 (Q1 2025), per Business Quant data.